ilmscore | Prediction Details
"for the last 8 months 10 months I'm seeing margin Improvement has picking up so this is an indication that valuation time correction CFE time correction valuations had become comfortable and now the margins are again improving growth in earnings is also picking up ... Indian companies who have good presence in cdmo they can really do well companies who have good presence in the US market Europe Market they can do well margins are improving"
By Learn Stock Market 1M+ | January 24, 2025 | Pending
From video
All Season Portfolio Strategy for Long-Term Stock Market Success !! #Face2Face with Aniruddha Sarkar 00:51:04 - 00:51:43
Interpreted Prediction
The Indian healthcare/pharma sector is expected to experience continued margin improvement and earnings growth, driven by comfortable valuations, normalized supply chains, and opportunities from US 'biocure act' for CDMOs with US/Europe presence.

Prediction Details

Topic
Indian Healthcare & Pharma Sector

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.